Viewing data from:

ECONAZOLE NITRATE

ANDA

ECONAZOLE NITRATE | A076005 | SUN PHARMA CANADA INC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 3 NDCs

Highest NADAC/Unit

$0.3990

per gm

Lowest NADAC/Unit

$0.2144

per gm

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
51672130301ECONAZOLE NITRATE 1% CREAM	$0.3990	GM	Generic	—	2026-08-19
51672130302ECONAZOLE NITRATE 1% CREAM	$0.3604	GM	Generic	—	2026-08-19
51672130308ECONAZOLE NITRATE 1% CREAM	$0.2144	GM	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 3 NDCs (3 FSS)

Lowest Price

$11.50

Highest Price

$38.98

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
51672-1303-01ECONAZOLE NITRATE 1% CREAM,TOP	$11.50	FSS	Golden State Medical Supply, Inc.	06/14/2028
51672-1303-02ECONAZOLE NITRATE 1% CREAM,TOP	$23.85	FSS	Golden State Medical Supply, Inc.	06/14/2028
51672-1303-08ECONAZOLE NITRATE 1% CREAM,TOP	$38.98	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain4 active DMFs6 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

FDC LTDECONAZOLE NITRATE USP

DMF 104561993

YUNG ZIP CHEMICAL IND CO LTDECONAZOLE NITRATE

DMF 111401994

OLON SPAECONAZOLE NITRATE

DMF 128571998

PMC ISOCHEMECONAZOLE NITRATE

DMF 268722013

CILAG CHEMIE AGInactiveECONAZOLE NITRATE

DMF 28771977

ERREGIERRE SPAInactiveECONAZOLE NITRATE

DMF 68691987

INDUSTRIE CHIMICHE FARMACEUTICHE ITALIANE SPAInactiveECONAZOLE NITRATE

DMF 75471988

GUANGDONG PHARMACEUTICAL FACTORYInactiveECONAZOLE NITRATE

DMF 113031994

GUFIC BIOSCIENCES LTDInactiveECONAZOLE NITRATE USP

DMF 127991997

SIFAVITOR SRLInactiveECONAZOLE

DMF 142371999

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Dec 24, 2003	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 1%

0 patents0 exclusivities▴

CREAM;TOPICAL | Approved: Nov 26, 2002

No patent or exclusivity listings for this strength.